We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Ezcorp Inc
EZPW
$1.71B
| $3.5K | ﹤0.01% |
418
| – | – |
|
1952
Paysafe
PSFE
$375M
| $3.5K | ﹤0.01% |
347
+157
| +83% | +$1.99K |
|
|
DHC
1953
Diversified Healthcare Trust
DHC
$2.14B
| $3.5K | ﹤0.01% |
1,555
-6,299
| -80% | -$9.04K |
|
1954
Alamo Group
ALG
$2.05B
| $3.49K | ﹤0.01% |
19
+9
| +90% | +$1.6K |
|
1955
Schrodinger
SDGR
$1.36B
| $3.49K | ﹤0.01% |
70
| – | – |
|
1956
Enpro
NPO
$7.05B
| $3.47K | ﹤0.01% |
26
| – | – |
|
1957
UWM Holdings
UWMC
$434M
| $3.46K | ﹤0.01% |
618
| – | – |
|
1958
Nokia
NOK
$52.3B
| $3.46K | ﹤0.01% |
831
-1,470
| -64% | -$6.22K |
|
|
MRUS
1959
DELISTED
Merus
MRUS
| $3.45K | ﹤0.01% |
131
-53
| -29% | -$1.16K |
|
1960
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $3.44K | ﹤0.01% |
84
+7
| +9% | +$271 |
|
1961
Capital City Bank Group
CCBG
$890M
| $3.43K | ﹤0.01% |
+112
| New | +$3.39K |
|
1962
Heartland Express
HTLD
$956M
| $3.43K | ﹤0.01% |
209
-32
| -13% | -$499 |
|
1963
Mid Penn Bancorp
MPB
$952M
| $3.42K | ﹤0.01% |
+155
| New | +$3.54K |
|
|
NXRT
1964
NexPoint Residential Trust
NXRT
$652M
| $3.41K | ﹤0.01% |
75
+54
| +257% | +$2.33K |
|
1965
Walker & Dunlop
WD
$1.53B
| $3.4K | ﹤0.01% |
43
+27
| +169% | +$1.95K |
|
1966
Freedom Holding
FRHC
$9.49B
| $3.39K | ﹤0.01% |
42
+10
| +31% | +$786 |
|
1967
Ardagh Metal Packaging
AMBP
$3.01B
| $3.38K | ﹤0.01% |
900
+746
| +484% | +$2.75K |
|
1968
York Water
YORW
$514M
| $3.38K | ﹤0.01% |
82
+29
| +55% | +$1.26K |
|
1969
Radian Group
RDN
$4.93B
| $3.36K | ﹤0.01% |
133
| – | – |
|
1970
CAVA Group
CAVA
$7.27B
| $3.36K | ﹤0.01% |
+82
| New | +$3.38K |
|
|
KAMN
1971
DELISTED
Kaman Corp
KAMN
| $3.36K | ﹤0.01% |
+138
| New | +$3.12K |
|
1972
Caleres
CAL
$487M
| $3.33K | ﹤0.01% |
139
| – | – |
|
|
RVNC
1973
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.32K | ﹤0.01% |
131
| – | – |
|
1974
Semtech
SMTC
$13B
| $3.31K | ﹤0.01% |
130
-311
| -71% | -$6.71K |
|
|
DQ
1975
Daqo New Energy
DQ
$996M
| $3.29K | ﹤0.01% |
83
+36
| +77% | +$1.5K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.